Reviewed clinical summary · Source-linked · Educational use only

Comparing Two Extended-Bolus Methods for Mixed Meals in Pediatric Type 1 Diabetes

Clinical Bottom Line

A crossover trial finds two extended-bolus algorithms both control post-meal glucose in adolescent type 1 diabetes; the simpler Sieradzki method trends better but not significantly. PICO summary and commentary.

Summary: In a crossover trial in adolescents with type 1 diabetes on pumps, two extended-bolus algorithms for a mixed meal both kept post-meal glucose within target range; the Sieradzki method gave numerically longer time in tight range and fewer late lows, but that difference was not statistically significant, while one-hour glucose was modestly higher with the Pankowska method.

PICO Summary

ElementDetail
Population58 adolescents with type 1 diabetes (median age 15.5) on insulin pumps and CGM in non-automated mode; randomised, double-blind, crossover trial, Poland.
InterventionSieradzki Equation (30% × carbohydrate units × insulin-to-carb ratio) as a 4-hour extended bolus for a standardised mixed meal.
ComparisonPankowska Equation (fat-protein units × insulin-to-carb ratio) as a 4-hour extended bolus.
OutcomeBoth methods kept postprandial glucose within the recommended time in range. The Sieradzki method gave longer time in tight range (82.5% vs 70.5%) and fewer hypoglycaemic episodes at 180 and 300 minutes, but the tight-range difference was not statistically significant (p=0.63). Glucose at 60 minutes was higher after Pankowska (136 vs 124 mg/dL; p=0.016).
RCT Nutrients · 2025

Sieradzki vs Pankowska extended bolus for mixed meals

RCT crossover · pediatric type 1 diabetes · 4-hour bolus

Trial design
58 adolescents, T1D on pumps Enrolled & assessed RANDOMISED crossover Sieradzki 30% extended bolus n = 58 Pankowska fat-protein unit bolus n = 58 Time in tight range post-meal
Proportion reaching endpoint
p=0.63 % time in tight range 82.5% Sieradzki 70.5% Pankowska ARR+12.0% absolute (NS)
Time in tight range
82.5% vs 70.5%
p=0.63 (NS)
Glucose at 60 min
124 vs 136 mg/dL
p=0.016
Late hypoglycaemia
Fewer
180 & 300 min
Both in target TIR
Yes
recommended range
⬡ Bottom Line

Both extended-bolus algorithms kept post-meal glucose in target. The simpler Sieradzki method trended toward longer tight-range time but the difference was not significant; Pankowska gave a modestly higher one-hour glucose.

Expert Commentary

This is a well-conducted, gold-standard crossover trial on a genuinely difficult problem, the delayed glucose rise after fat- and protein-rich meals that simple carbohydrate counting cannot cover. The honest headline, though, is that both algorithms worked and that the trial does not establish one as clearly superior. The eye-catching tight-range difference, 82.5% versus 70.5%, did not reach statistical significance at p=0.63, so it should be read as a numerical trend rather than a proven advantage, and the only statistically significant between-method finding was a modestly higher one-hour glucose with the Pankowska approach. What can be said fairly is that the simpler Sieradzki calculation performed at least as well as the more complex fat-protein-unit method, which matters because simplicity aids real-world adoption by families. Limitations include standardised meals that do not capture real-life variability, a single mixed-meal composition, and non-automated pump mode, so results may differ with automated insulin delivery. Can I use this with my patients? Yes, pragmatically. For adolescents on pumps struggling with high-fat meals, it supports using an extended bolus and suggests the easier 30% method is a reasonable default, while I would individualise the dose and duration using CGM feedback rather than treating either equation as definitively better.

References

Dymińska M, Kowalczyk-Korcz E, Piechowiak K, Szypowska A. The impact of two different insulin dose calculation methods on postprandial glycemia after a mixed meal in children with type 1 diabetes: a randomized study. Nutrients. 2025;17(20):3287. doi:10.3390/nu17203287

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.